Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
5.10
+0.04 (0.79%)
At close: Jun 4, 2026

EGX:RMDA Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,2006,6605,0222,4592,8922,400
Market Cap Growth
45.90%32.63%104.18%-14.96%20.51%-18.04%
Enterprise Value
12,4868,9195,8813,2593,2843,006
Last Close Price
5.103.312.451.171.391.12
PE Ratio
35.5524.7913.8011.0012.6314.42
Forward PE
15.759.1910.847.729.2510.10
PS Ratio
2.371.631.811.281.951.93
PB Ratio
4.533.012.421.391.901.78
P/TBV Ratio
9.266.303.372.102.732.50
P/FCF Ratio
-----12.72
P/OCF Ratio
----98.559.94
PEG Ratio
0.520.280.280.280.280.27
EV/Sales Ratio
2.912.182.121.702.212.41
EV/EBITDA Ratio
11.578.537.316.338.149.49
EV/EBIT Ratio
12.649.278.117.319.6010.96
EV/FCF Ratio
-55.25----15.93
Debt / Equity Ratio
1.011.090.760.630.610.65
Debt / EBITDA Ratio
2.122.281.942.152.282.75
Debt / FCF Ratio
-----4.66
Net Debt / Equity Ratio
1.001.070.630.450.330.30
Net Debt / EBITDA Ratio
2.102.271.631.561.241.26
Net Debt / FCF Ratio
-9.93-11.89-3.53-5.91-99.722.11
Asset Turnover
0.880.850.740.640.570.53
Inventory Turnover
2.452.372.823.132.522.37
Quick Ratio
0.410.380.530.540.620.76
Current Ratio
1.171.151.461.471.491.44
Return on Equity (ROE)
14.99%14.63%20.89%15.35%17.63%14.24%
Return on Assets (ROA)
12.60%12.47%12.04%9.30%8.24%7.34%
Return on Invested Capital (ROIC)
16.02%17.85%18.59%14.98%13.99%12.53%
Return on Capital Employed (ROCE)
41.10%40.90%33.60%24.20%21.50%19.60%
Earnings Yield
2.83%4.48%7.71%9.96%8.49%7.54%
FCF Yield
-2.22%-3.00%-7.41%-5.51%-0.17%7.86%
Dividend Yield
0.79%-1.64%4.32%--
Payout Ratio
59.22%63.30%31.31%6.85%9.89%8.12%
Buyback Yield / Dilution
0.01%-0.02%-1.11%-1.27%2.62%-
Total Shareholder Return
0.81%-0.02%0.53%3.04%2.62%-